3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Organisation

RCHT

Source

Lancet Oncology; Apr 2018; vol. 19 (no. 4); p. 562-578

Access

OpenAthens
ClinicalKey

Authors (Bold indicates local authors)

• Allan, Karen;
• Boyd, Kathleen A;
• Briggs, Andrew H;
• Cassidy, Jim;
• Dhadda, Amandeep S;
• Ellis, Richard;
• Essapen, Sharadah;
• Glimelius, Bengt;
• Harkin, Andrea;
• Haydon, Andrew;
• Hollander, Niels Henrik;
• Iveson, Timothy;
• Kerr, Rachel S;
• McQueen, John;
• Medley, Louise;
• Saunders, Mark P;
• Scudder, Claire;
• Tabernero, Josep;
• Waterston, Ashita;
• Wilson, Charles;

If you have any queries about a journal please contact us.